During the past decade, Xi'an Central Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Xi'an Central Hospital" #1 sponsor was "First Affiliated Hospital Xi'an Jiaotong University" with 3 trials, followed by "Xijing Hospital" with 2 trials sponsored, "Air Force Military Medical University, China" with 1 trials sponsored, "Chinese University of Hong Kong" with 1 trials sponsored and "Green Valley (Shanghai) Pharmaceuticals Co., Ltd." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Xi'an Central Hospital" #1 collaborator was "Xi'an Central Hospital" with 5 trials as a collaborator, "Shaanxi Provincial People's Hospital" with 3 trials as a collaborator, "Ankang Central Hospital" with 2 trials as a collaborator, "Ankang Hospital of Traditional Chinese Medicine" with 2 trials as a collaborator and "Baoji Central Hospital" with 2 trials as a collaborator. Other collaborators include 113 different institutions and companies that were collaborators in the rest 117 trials.

According to Clinical.Site data, the most researched conditions in "Xi'an Central Hospital" are "Virus Diseases" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Stroke" (1 trials), "Alzheimer Disease" (1 trials) and "Colonoscopy" (1 trials). Many other conditions were trialed in "Xi'an Central Hospital" in a lesser frequency.

Most popular intervention types in "Xi'an Central Hospital" are "Drug" (8 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "3 L PEG + linaclotide" (1 trials), "3 L PEG + placebo" (1 trials), "Acarbose" (1 trials), "Bifidobacterium tetrad live bacteria tablet placebo plus Helicobacter pylori quadruple eradication therapy" (1 trials) and "Bifidobacterium tetrad live bacteria tablet plus Helicobacter pylori quadruple eradication therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Xi'an Central Hospital" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Xi'an Central Hospital". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Xi'an Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Xi'an Central Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".